Home › GLP-1 Medications › Orforglipron
Latest four-week snapshot through 2026-08-05 · 1 wave. Use the controls above to change the window.
GLP-1 Medications · 1 wave · n=72 answers, pooled
How often each assistant brings the brand up in recommendation answers.
| assistant | share of voice | answers |
|---|---|---|
| ChatGPT | 4% | 1 of 24 |
| Claude | 8% | 2 of 24 |
| Gemini | 0% | 0 of 24 |
Wave-by-wave share of recommendation answers that named this brand.
| wave | share of voice | answers | change |
|---|---|---|---|
| 2026-08-05 | 4% | 3 of 72 |
Recurring descriptions in the assistants' own words, grouped by theme.
“- Orforglipron at $149/month — cheaper than compounded semaglutide ever was; LillyDirect Zepbound at $299/month — brand-name tirzepatide at a fraction of list price”
“- **Orforglipron** (Lilly's oral GLP-1, pending FDA approval): Orforglipron costs $149/month at LillyDirect with no fasting requirement; produces ~12.”
“- **Orforglipron** (Lilly's oral GLP-1, pending FDA approval): Orforglipron costs $149/month at LillyDirect with no fasting requirement; produces ~12.”
“- **Orforglipron** – an oral option costing $149/month at LillyDirect with no fasting requirement, producing about 12.4% weight loss (pending full FDA approval for weight loss).”
“Compounded semaglutide generally costs less than brand-name Ozempic, with prices ranging from $200 to $500 per month depending on the pharmacy and dosage.”
“Emerging drugs like orforglipron and retatrutide are showing promise, with one source noting retatrutide showing 28.”
“The market has shifted with new competitively-priced FDA-approved drugs:”
“However, this comes with real trade-offs: while it tends to be more affordable than the brand-name, FDA-approved drugs, compounded semaglutide is not FDA-approved and is not usually covered by health insurance.”
“** LillyDirect offers Zepbound at $299/month self-pay through December 2026, down from $1,060/month list, and orforglipron is priced around $149/month — the lowest brand-name price.”
“- **Orforglipron** — a newer oral option priced at $149/month at LillyDirect with no fasting requirement, producing ~12.”
12 exact quoted mentions in this snapshot, grouped by coded tone.
“orforglipron is priced around $149/month — the lowest brand-name price.”
“Lilly's Zepbound and orforglipron are available at an average of $346”
“Orforglipron at $149/month is cheaper than compounded semaglutide ever was”
“Orforglipron is priced at $149/month — cheaper than compounded semaglutide ever was”
“Brand-name alternatives have become more affordable: Orforglipron at $149/month, LillyDirect Zepbound at $299/month, and Oral Wegovy at $199-299/month.”
“Emerging drugs like orforglipron and retatrutide are showing promise, with one source noting retatrutide showing 28.7% weight loss in Phase 2 trials, with Phase 3 (TRIUMPH-1) ongoing — but these aren't fully approved/available yet, so discu”
“Foundayo (orforglipron, daily pill)”
Which competitors assistants suggest when shoppers ask for something cheaper.
0 of 12 mentions appear alongside an identifiable web citation. Citation does not establish causation.
| cited source | mentions |
|---|
Stores and sites assistants name as places to buy this brand.
| retailer | mentions |
|---|---|
| LillyDirect | 3 |
Method: fixed shopper questions asked repeatedly to Claude, OpenAI GPT and Gemini with web search on. Shares are the percentage of recommendation answers mentioning the brand. Quotes are AI outputs; full transcripts are kept as receipts.